Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Peregrine Pharmaceuticals Inc. (PPHM)

4.114 +0.034 (+0.833%)

10/23/2017  10:46am

Open:

4.110

Pre. Close:

4.080

High:

4.120

Low:

4.030

Volume:

32,381

Market Cap:

185.52M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

4.21 - 4.28

4.28 - 4.4

Low:

3.84 - 3.88

3.88 - 3.96

Close:

4 - 4.09

4.09 - 4.24

Technical analysis  (as of: 2017-10-23 10:34:32 AM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 4.93     One year: 5.76

Support:

Support1: 3.48    Support2: 3.02

Resistance:

Resistance1: 4.22    Resistance2: 4.93

Pivot:

3.71

Moving Averages:

MA(5): 4.01     MA(20): 3.57

MA(100): 3.80     MA(250): 3.45

MACD:

MACD(12,26): 0.22     Signal(12,26,9): 0.15

%K %D:

%K(14,3): 90.52     %D(3): 84.97

RSI:

RSI(14): 69.23

52-Week:

High: 5.780  Low: 1.974  Change(%): 68.2

Average Vol(K):

3-Month: 22527  10-Days 25136

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
PPHM has closed below upper band by 17.4%. Bollinger Bands are 37.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 21 Sep 2017 13:07:30 GMT
Un-Spinning The Peregrine Pharmaceuticals Spin Zone

Fri, 11 Aug 2017 14:43:02 GMT
Peregrine Pharmaceuticals Axing 20% of Workforce, 60 Jobs, in Restructuring

Mon, 11 Sep 2017 20:03:45 GMT
Peregrine Pharmaceuticals Reports Financial Results for First Quarter of ...

Thu, 19 Oct 2017 12:00:00 GMT
Peregrine Pharmaceuticals Announces Appointment of Mark R. Bamforth to Board ...

Thu, 07 Sep 2017 12:00:00 GMT
Peregrine Pharmaceuticals Announces First Patient Dosed in Phase II Clinical ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biopharmaceuticals

Shares Out. (M)

45.00

Shares Float (M)

40.86

% Held by Insiders

17.38

% Held by Institutions

16.27

Shares Short (K)

611

Shares Short Prior Month (K)

432

Stock Financials

EPS

-0.580

EPS Est. Current Year

-0.440

EPS Est. Next Year

-0.460

EPS Est. Next Quarter

-0.120

Forward EPS

1.#IO

Book Value (p.s.)

1.240

PEG Ratio

Profit Margin

-23.15

Operating Margin

-23.27

Return on Assets (ttm)

-11.2

Return on Equity (ttm)

-37.8

Qtrly Rev. Growth

382.7

Gross Profit (p.s.)

0.429

Sales Per Share

1.758

EBITDA (p.s.)

-0.387

Qtrly Earnings Growth

Operating Cash Flow (M)

Levered Free Cash Flow (M)

FoxReading.com

Valuation

P/E

-7.10

P/E Growth Ratio

0.01

P/BV

3.32

P/S

2.34

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2017-07-10

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.